<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03161704</url>
  </required_header>
  <id_info>
    <org_study_id>ENDOmarker</org_study_id>
    <nct_id>NCT03161704</nct_id>
  </id_info>
  <brief_title>Validation and Refinement of Noninvasive Diagnostic Biomarkers for Endometriosis, The ENDOmarker Protocol</brief_title>
  <official_title>Validation and Refinement of Noninvasive Diagnostic Biomarkers for Endometriosis, The ENDOmarker Protocol</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yale University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Augusta University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Penn State University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of California, San Francisco</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of North Carolina</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Oklahoma</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Pennsylvania</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Yale University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study involves the prospective collection of endometrial biopsy tissue, serum, plasma,
      whole blood for DNA extraction, and urine from women who will be diagnosed as having (or not
      having) endometriosis at the time of scheduled surgery. The investigators plan to enroll
      approximately 500 women to validate and optimize the use of genomic classifiers alone or in
      combination with serum markers (such as cytokines) as a non-surgical marker of disease.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>July 8, 2016</start_date>
  <completion_date type="Anticipated">January 2021</completion_date>
  <primary_completion_date type="Anticipated">January 2021</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>3 Months</target_duration>
  <primary_outcome>
    <measure>Collection of up to 3 2cm samples of Endometrial Tissue</measure>
    <time_frame>2 collection timepoints: baseline and up to 18 weeks following surgery.</time_frame>
    <description>Up to 3 2cm samples will be collected per collection.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Collection of Serum 1 will be 2 10ml serum tubes of serum</measure>
    <time_frame>3 collection timepoints: baseline, up to 14 days following surgery and up to 18 weeks following surgery.</time_frame>
    <description>2 10ml serum tubes will be drawn at each collection, up to 10 1.0ml aliquots per collection.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Collection of Serum 2 will be 2 7 ml serum tubes of serum</measure>
    <time_frame>3 collection timepoints: baseline, up to 14 days following surgery and up to 18 weeks following surgery.</time_frame>
    <description>2 7ml serum tubes drawn at each collection, up to 10 1.0ml aliquots of serum plus 1 15ml conical tube with the 2 blood clots per collection.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Collection of Plasma in 1 4ml EDTA tube</measure>
    <time_frame>3 collection timepoints: baseline, up to 14 days following surgery and up to 18 weeks following surgery.</time_frame>
    <description>1 4ml EDTA tube will be drawn at each collection, up to 3 1.0ml aliquots per collection.</description>
  </other_outcome>
  <other_outcome>
    <measure>Collection of Whole Blood in 2 4ml EDTA tubes</measure>
    <time_frame>3 collection timepoints: baseline, up to 14 days following surgery and up to 18 weeks following surgery.</time_frame>
    <description>2 4ml EDTA tubes will be drawn at each collection, up to 2 4.5ml aliquots as well as 1 FTA blood spot collection card per collection.</description>
  </other_outcome>
  <other_outcome>
    <measure>Collection of Urine will be one complete sample as produced by the subject</measure>
    <time_frame>3 collection timepoints: baseline, up to 14 days following surgery and up to 18 weeks following surgery.</time_frame>
    <description>1 urine sample will be collected each time, up to 6 15ml aliquots and 5 1.5ml aliquots per collection will be taken.</description>
  </other_outcome>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Endometriosis</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Collection of endometrial biopsy tissue, serum, plasma, whole blood for DNA extraction and
      urine
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Females aged 18-44 who are scheduled to undergo gynecologic surgery
        (laparoscopy/laparotomy). Indications for surgery can include: infertility, endometriosis,
        tubal ligation, lysis of adhesions, pelvic pain, hysterectomy (for benign condition),
        myomectomy, salpingo-oophorectomy, cystectomy, or diagnostic laparoscopy.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  â€¢ Currently pregnant

               -  Current or past diagnosis of any malignancy (with the exception of non-melanoma
                  skin cancer)

               -  Known to be HIV-positive

               -  Unable to give informed consent

               -  Unwillingness to have samples banked in Repository for future use

               -  Clinical evidence of active cervical infection

               -  Lupron (or other GRH agonist) therapy within the last 2 months (or Depo-Lupron
                  within the last 4 months)

               -  Current use of estrogen or progestin (oral, transdermal, intrauterine or ring).

                  o Current use is defined as use in the index menstrual cycle (since the onset of
                  the last menstrual period).

               -  Use of depo estrogen or progestin in last 3 months

               -  Current use of aromatase inhibitor

        Exclusion Criteria:

          -  Women aged 18-44 scheduled to undergo gynecologic surgery (laparoscopy/laparotomy).

        Indication for surgery can include: infertility, endometriosis, tubal ligation, lysis of
        adhesions, pelvic pain, hysterectomy (for benign condition), myomectomy,
        salpingo-oophorectomy, cystectomy, or diagnostic laparoscopy.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>44 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kurt Barnhart, MD MSCE</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Pennsylvania</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Esther Eisenberg, MD MPH</last_name>
    <role>Study Director</role>
    <affiliation>Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Nanette Santoro, MD</last_name>
    <role>Study Chair</role>
    <affiliation>University of Colorado, Denver</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Michael Diamond, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Augusta University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Richard Legro, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Milton S. Hershey Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Marcelle Cedars, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, San Francisco</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Anne Steiner, MD MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of North Carolina</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Karl Hansen, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Oklahoma</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Christos Coutifaris, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Pennsylvania</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Heping Zhang, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Yale University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Augusta University</name>
      <address>
        <city>Augusta</city>
        <state>Georgia</state>
        <zip>30912</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Candelario (Andy) Laserna</last_name>
      <phone>706-721-9680</phone>
      <email>CALASERNA@augusta.edu</email>
    </contact>
    <investigator>
      <last_name>Michael Diamond, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Wayne State University</name>
      <address>
        <city>Southfield</city>
        <state>Michigan</state>
        <zip>48034</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Michelle Yoscovits</last_name>
      <phone>248-352-8200</phone>
      <phone_ext>1032</phone_ext>
      <email>mbrossoi@med.wayne.edu</email>
    </contact>
    <contact_backup>
      <last_name>Laure Cedo</last_name>
      <phone>248-352-8200</phone>
      <phone_ext>1032</phone_ext>
      <email>lcedo@med.wayne.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Puscheck Elizabeth, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Pennsylvania State University</name>
      <address>
        <city>Hershey</city>
        <state>Pennsylvania</state>
        <zip>17033</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Heidi Watts</last_name>
      <phone>717-531-6272</phone>
      <email>hwatts@pennstatehealth.psu.edu</email>
    </contact>
    <investigator>
      <last_name>Richard Legro, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wahid Youseff</last_name>
      <phone>215-615-4890</phone>
      <email>wahid.youssef@uphs.upenn.edu</email>
    </contact>
    <investigator>
      <last_name>Kurt Barnhart, MD, MSCE</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Christos Coutifaris, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 13, 2015</study_first_submitted>
  <study_first_submitted_qc>May 18, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 22, 2017</study_first_posted>
  <last_update_submitted>April 16, 2018</last_update_submitted>
  <last_update_submitted_qc>April 16, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 17, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Endometriosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

